Trastuzumab-Dttb (Intravenous Route)

Name: Trastuzumab-Dttb (Intravenous Route)

US Brand Name

  1. Ontruzant

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of trastuzumab-dttb injection in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of trastuzumab-dttb injection in the elderly. However, elderly patients are more likely to have age-related heart problems, which may require caution in patients receiving this medicine.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

  • Heart disease (eg, cardiomyopathy, heart failure) or
  • Heart rhythm problems (eg, arrhythmia) or
  • Hypertension (high blood pressure) or
  • Lung disease (eg, interstitial pneumonitis, pulmonary fibrosis)—Use with caution. May make these conditions worse.
  • Infection—May decrease your body's ability to fight infection.
(web3)